What are the potential interactions between lamotrigine and hydroxyzine?

Lamotrigine and Hydroxyzine: No Clinically Significant Pharmacokinetic Interaction

Lamotrigine and hydroxyzine can be safely used together without dose adjustments, as there is no evidence of clinically significant pharmacokinetic or pharmacodynamic interactions between these two medications. However, be aware of additive CNS depression effects and hydroxyzine's potential to prolong the QT interval.

Key Clinical Considerations

No Direct Drug Interaction

Based on available evidence, there is no documented pharmacokinetic interaction between lamotrigine and hydroxyzine:

• Lamotrigine metabolism: Primarily metabolized via glucuronidation (UGT enzymes), not significantly affected by CYP450 enzymes 1, 2, 3
• Hydroxyzine metabolism: Metabolized via CYP450 system but does not induce or inhibit enzymes that affect lamotrigine 4
• Research evidence: A systematic therapeutic drug monitoring study of 829 patients found no significant effect of hydroxyzine on lamotrigine serum concentrations 2

Important Safety Warnings

CNS Depression (Additive Effect) Both medications can cause sedation, and their effects may be additive 4:

• Hydroxyzine causes drowsiness and performance impairment in many patients 5
• Warn patients explicitly about increased sedation risk, impaired driving ability, and cognitive effects
• The FDA label states: "THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS" 4
• Avoid alcohol and other CNS depressants 4

QT Prolongation Risk with Hydroxyzine Hydroxyzine carries a risk of QT prolongation and torsade de pointes 4, 6:

• Use caution in patients with cardiac risk factors, electrolyte imbalances, or congenital long QT syndrome
• Avoid combining with other QT-prolonging medications (Class IA/III antiarrhythmics, certain antipsychotics, azithromycin, etc.) 4
• Consider baseline ECG in high-risk patients

Practical Management Algorithm

1. Before initiating combination therapy:

   • Screen for cardiac risk factors (personal/family history of long QT, recent MI, heart failure)
   • Check electrolytes (K+, Mg2+) if clinically indicated
   • Review all medications for other QT-prolonging agents

2. Dosing:

   • No adjustment needed for either medication based on the combination
   • Start hydroxyzine at low doses in elderly patients (increased sensitivity to sedation and anticholinergic effects) 4
   • Lamotrigine dosing follows standard protocols based on comedications (especially valproate or enzyme inducers)

3. Monitoring:

   • Counsel patients about additive sedation—avoid driving until effects are known
   • Watch for excessive drowsiness, confusion (especially in elderly), or anticholinergic effects
   • If cardiac risk factors present, consider ECG monitoring

Common Clinical Scenario

This combination is occasionally seen in practice when hydroxyzine is used for anxiety or pruritus in patients taking lamotrigine for bipolar disorder or epilepsy 7. The case report of a patient taking both medications (along with other psychotropics) demonstrates this combination is used clinically, though the focus was on a false-positive drug screen rather than an interaction 7.

Critical Pitfalls to Avoid

• Don't assume hydroxyzine is "just an antihistamine"—it has significant CNS depressant effects and cardiac risks 4
• Don't overlook elderly patients—they are particularly vulnerable to sedation, falls, cognitive impairment, and anticholinergic effects from hydroxyzine 5, 4
• Don't forget to check for other QT-prolonging medications in the patient's regimen before adding hydroxyzine 4
• Don't use first-generation antihistamines like hydroxyzine as first-line when second-generation nonsedating antihistamines would suffice 5, 8